Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care [PDF]
Cancer Medicine, 2018 The role of induction chemotherapy in nasopharyngeal carcinoma (NPC) remains controversial. The primary aim of this study was to use the National Cancer Database to evaluate the patterns of care of induction chemotherapy in NPC and its impact on overall ...
Prashant Gabani +10 more
doaj +3 more sources
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. [PDF]
PLoS ONE, 2014 BackgroundInduction chemotherapy is a common therapeutic option for patients with locoregionally-advanced head and neck cancer (HNC), but it remains unclear which patients will benefit. In this study, we searched for biomarkers predicting the response of
Tanguy Y Seiwert +13 more
doaj +7 more sources
Induction chemotherapy with nedaplatin, docetaxel and 5-fluorouracil followed by concurrent nedaplatin and radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A single arm, open label, phase II clinical trial [PDF]
Translational OncologyPurpose: To evaluate the efficacy of nedaplatin in induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Fang-Zheng Chen +14 more
doaj +2 more sources
Orbital Myeloid Sarcoma in Acute Myeloid Leukemia: A Case Report [PDF]
International Journal of Scientific Research in Dental and Medical Sciences, 2022 Orbital myeloid sarcoma is a common presentation in acute myeloid leukemia. A 6 years old girl child presented with progressive proptosis of the left eye for two weeks with associated redness, watering, and reduced vision in the left eye.
Kishalay Baidya +3 more
doaj +1 more source
Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma. [PDF]
PLoS ONE, 2016 PURPOSE:The value of adding induction chemotherapy to chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains controversial, yet high-risk patients with LA-NPC have poor outcomes after chemoradiotherapy.
Xiao-Wen Lan +6 more
doaj +1 more source
Medicina, 2023 Background and Objectives: This study aimed to evaluate whether the addition of hypomethylating agents (HMA) to low-intensity chemotherapy can enhance the clinical efficacy of induction treatment for elderly acute myeloid leukemia (AML) patients who are ...
Dan Liu +9 more
doaj +1 more source
Frontiers in Oncology, 2021 BackgroundFluoropyrimidine with platinum-based chemotherapy has become the standard of care for advanced gastric and gastroesophageal (GEJ) cancer.
Daniel Walden +6 more
doaj +1 more source
World Journal of Surgical Oncology, 2022 Background Although patients with positive lavage cytology (CY1) are classified as having stage IV disease, long-term survival without other unresectable factors (P0CY1) has been reported.
Akikazu Yago +6 more
doaj +1 more source
International Journal of Hyperthermia, 2021 Background Hyperthermia has been reported to cause cancer stage regression, thus providing surgical opportunities in patients with unresectable tumors and improving the quality of life of patients by preserving certain organs.
Guoxin Ren +11 more
doaj +1 more source
IMPACT OF NUTRITIONAL STATUS ON INDUCTION MORTALITY IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA
Khyber Medical University Journal, 2021 OBJECTIVE: To study the impact of nutritional status on induction mortality among pediatric patients suffering from acute lymphoblastic leukemia (ALL).
Muhammad Tahir +5 more
doaj +1 more source